ASHLEY HYATT: Open Payments
NPI 1578984456 · THORNTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,305 in 120 payments from 19 companies in 2025. Trend: 2023 $1,728 · 2024 $2,772 · 2025 $4,305
Food & beverage: $2,978Consulting: $1,245Travel & lodging: $42Education: $40
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $1,626 |
| ABBVIE INC. | 26 | $599 |
| Gilead Sciences, Inc. | 17 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $263 |
| GENZYME CORPORATION | 6 | $250 |
| Phathom Pharmaceuticals, Inc. | 5 | $245 |
| Lilly USA, LLC | 6 | $218 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $151 |
| Janssen Scientific Affairs, LLC | 1 | $120 |
| PFIZER INC. | 5 | $97 |
Products named: TREMFYA, DUPIXENT, RINVOQ, VOQUEZNA, OMVOH, ENTYVIO, XIFAXAN, REZDIFFRA.
Industry payments across CO — which companies pay providers there.
